Halozyme Therapeutics, Inc.
2020 Q4 - 2025 Q4 (21 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/4/2026 | 1,579 | 0.0% | 23,462 | 12/31/2025 |
| 2025 Q3 | 10/24/2025 | 1,728 | 0.0% | 23,562 | 9/30/2025 |
| 2025 Q2 | 7/25/2025 | 1,313 | 0.0% | 25,239 | 6/30/2025 |
| 2025 Q1 | 4/28/2025 | 1,649 | 0.0% | 25,839 | 3/31/2025 |
| 2024 Q4 | 2/5/2025 | 1,240 | 0.0% | 25,939 | 12/31/2024 |
| 2024 Q3 | 10/29/2024 | 1,479 | 0.0% | 25,839 | 9/30/2024 |
| 2024 Q2 | 8/2/2024 | 1,383 | 0.0% | 26,409 | 6/30/2024 |
| 2024 Q1 | 5/3/2024 | 1,327 | 0.0% | 32,609 | 3/31/2024 |
| 2023 Q4 | 2/12/2024 | 1,374 | 0.0% | 37,164 | 12/31/2023 |
| 2023 Q3 | 10/27/2023 | 1,412 | 0.0% | 36,959 | 9/30/2023 |
| 2023 Q2 | 7/26/2023 | 1,373 | 0.0% | 38,059 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 1,507 | 0.0% | 39,459 | 3/31/2023 |
| 2022 Q4 | 1/26/2023 | 2,290 | 0.0% | 40,243 | 12/31/2022 |
| 2022 Q3 | 11/2/2022 | 1,592 | 0.0% | 40,265 | 9/30/2022 |
| 2022 Q2 | 7/25/2022 | 1,788 | 0.0% | 40,629 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 1,795 | 0.0% | 44,998 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 1,854 | 0.0% | 46,098 | 12/31/2021 |
| 2021 Q3 | 10/19/2021 | 1,935 | 0.0% | 47,558 | 9/30/2021 |
| 2021 Q2 | 7/23/2021 | 2,074 | 0.0% | 45,675 | 6/30/2021 |
| 2021 Q1 | 4/20/2021 | 1,763 | 0.0% | 42,281 | 3/31/2021 |
| 2020 Q4 | 2/9/2021 | 1,619 | 0.0% | 37,911 | 12/31/2020 |